Featured Posts
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Blog
FDA’s Moderna decision demonstrates how science and government are incompatible
Last week, the FDA announced that it would not be considering Moderna’s application for a new flu vaccine because the control group Moderna used…
Search Posts
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. SPAM E-MAIL Spam “zombies”—computers that are hijacked to send out a spammer’s unwanted email messages—get…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. TECHNOLOGY A small group of U.S. House members is proposing new federal rules for disposal…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. CIVIL LIBERTIES The Senate Select Committee on Intelligence begins debate over whether to renew…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. ECONOMIC LIBERTY The union campaign against Wal-Mart expands in the Washington,…
Op-Eds
Infant Formula Fanatics Should Stop Milking the Issue, by Henry Miller
Self-styled public health activists often pursue issues that are surrogates for their real agenda. One example is the continuing attack on infant formula. The…
Op-Eds
If Wishes Were Horses, This Would Be the Kentucky Derby
GENEVA, Switzerland—The 58th World Health Assembly (the World Health Organization's policy-making body) under way here brings to mind the cliché about the contestants…